Loading clinical trials...

Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL) | Clinical Trials | Clareo Health

TERMINATED

Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)

Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic Lymphocytic Leukaemia Or Indolent Non Hodgkin's Lymphoma

NCT02273856•Astellas Pharma International B.V.

View on ClinicalTrials.gov

Summary

The purpose of this study is to document the pharmacological treatment strategies used in treatment naïve and previously treated relapsed/refractory iNHL/CLL patients in the Middle East and North African (MENA) region. This study will also record encountered tumor subtype and stage and the instituted pharmacological treatments, as well as assess the clinical outcomes of treatments.

Detailed Description

Patients will be followed up to 30 months.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Informed consent
•CLL patients or
•iNHL patients
•Clinical decision made to initiate or adapt treatment of CLL/iNHL("Need to treat")

Exclusion Criteria

•Patient deemed unfit for enrollment by the documented opinion of the investigator
•Watch and wait patients
•Richter's transformation
•Moribund patients

Locations (8)

Site JO96201 King Abdullah University Hospital

Irbid, Irbid Governorate, Jordan

Site KW96501 Kuwait Cancer Control Center

Ash Shuwaykh, Shuwaikh, Kuwait

Site Hammoud Hospital University Medical Center

Beirut, Beyrouth, Lebanon

Site Hotel Dieu De France

Beirut, Beyrouth, Lebanon

Site OM96801 Sultan Qaboos University Hospital

Muscat, Muḩāfaz̧at Masqaţ, Oman

Site Hamad Medical Coorporation, National Center for Cancer Care and Research, Al Amal Hospital

Doha, Baladīyat ad Dawḩah, Qatar

Site SA96601 Aseer Central Hospital

Abhā, 'Asir Region, Saudi Arabia

Site AE97101 Sheikh Khalifa Medical City

Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates

Key Dates

Start Date

January 1, 2015

Primary Completion Date

August 1, 2015

Completion Date

August 1, 2015

Last Updated

June 21, 2016

Enrollment

ACTUAL participants

Conditions

Indolent Non Hodgkin's Lymphoma (iNHL)Chronic Lymphocytic Leukaemia (CLL)

AZD6738 First Time in Patient Multiple Ascending Dose Study

NCT01955668

11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL),Prolymphocytic Leukaemia (PLL)+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 21, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions